Terumo Corporation has officially unveiled its K-Pack Embrace™ active safety needle, a groundbreaking product engineered to streamline the co-packing of injectable drug products and improve safety standards across the healthcare industry. This innovative needle is meticulously encased within a robust cap and case, offering superior protection and maintaining sterility throughout its journey from manufacturing to point of care. The design specifically caters to automated co-packing procedures, ensuring seamless integration and consistent performance.
The primary motivation behind the K-Pack Embrace™ is to mitigate risks for both patients and healthcare professionals while simultaneously providing pharmaceutical companies with a cost-effective and efficient packaging solution. By offering enhanced hard-shell protection, the needle can be easily handled during automated co-packing, safeguarding its sterility and integrity over an extended shelf life. This advancement represents a significant step forward in the delivery of injectable drug therapies.
Incorporating Terumo's cutting-edge T-Sharp™ technology, the K-Pack Embrace™ active safety needle is suitable for a wide range of medical applications, including subcutaneous (SC), intramuscular (IM), and intravenous (IV) injections. Its design features integrated needle shield safety mechanisms, which are crucial in preventing accidental needle stick injuries—a persistent concern in clinical settings. The needle is available in 1-inch (25 mm) and 5/8-inch (16 mm) lengths, making it versatile for various clinical needs.
Furthermore, the K-Pack Embrace™ boasts compatibility with all ISO 80369-7 male connectors, ensuring broad usability with existing medical devices. Each needle is equipped with a color-coded, tamper-evident label that includes a 2D barcode (UDI carrier), facilitating automated in-line visual inspection and enhancing traceability. The integrated hinged needle shield can be activated with one hand, providing clear audible, visual, and tactile confirmations of engagement, thus reducing user error and increasing confidence in its safety features.
Nicolas Eon, Global Product Manager for Injection and Infusion Platforms at Terumo Corporation's Pharmaceutical Solutions Division, highlighted the product's alignment with their 'Deviceutical™' approach. This philosophy emphasizes the synergistic integration of medical devices and pharmaceuticals to create comprehensive drug delivery solutions. Marco Chiado Piat, President of the Pharmaceutical Solutions Division, added that the K-Pack Embrace™ actively protects healthcare professionals, patients, and the product itself, while simultaneously unlocking new efficiencies in automated co-packing for their pharmaceutical clients. This new safety needle underscores Terumo's commitment to developing injectable drug delivery solutions that genuinely enhance patient well-being.
The introduction of the K-Pack Embrace™ active safety needle marks a significant milestone in medical device innovation, promising a safer and more streamlined process for drug administration. This development reflects a dedication to improving patient outcomes and protecting healthcare workers through thoughtfully engineered medical solutions.
